Latest News

The Kingdom’s digital health market is projected to reach US$11.07 billion by 2033, highlighting growing demand for advanced healthcare technologies.

Through its dedicated pavilion, BIRAC is connecting visitors, investors and industry leaders with emerging Indian innovators while highlighting how its funding, infrastructure and mentorship programmes help turn scientific research into market-ready products.

The initiative aims to help patients with the greatest medical needs access modern therapies within a coordinated framework that complements the UAE’s national health insurance system.

The procedure marks another milestone for the UAE in treating complex pediatric immune disorders and expanding access to advanced bone marrow transplantation.

The latest approval expands the clinical use of ivonescimab in China and follows previous NMPA authorisations for regimens containing the molecule.

The FDA approval was supported by findings from the Phase 3a ONWARDS clinical program, which evaluated once-weekly Awiqli® in adults with type 2 diabetes.

The transaction will be completed through a share purchase agreement with SEVER Life Sciences, under which Alfasigma will acquire 100% of Nordic Group and its subsidiaries.

The complex includes dedicated maternity and paediatric areas, with a total capacity of 66 beds and several functional units designed to improve patient reception, treatment and care.

The U.S. National Cancer Institute estimates that more than 500 rare cancers exist, many of which receive limited public attention despite their significant impact on patients and families.

The researchers say the finding could help guide the development of more targeted treatment combinations for patients whose tumors produce the protein.